Claim Missing Document
Check
Articles

Found 3 Documents
Search
Journal : Berkala Kedokteran

Compliance of Pharmacy Service Standards at The Phcussia of Banjarmasin City Nufus, Hayatun; Aryzki, Saftia; Malahayati, Siti; Kurniawati, Darini
Berkala Kedokteran Vol 20, No 2 (2024)
Publisher : Fakultas Kedokteran Universitas Lambung Mangkurat

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20527/jbk.v20i2.20596

Abstract

Pharmaceutical work carried out in the acquisition, production, distribution and maintenance of drugs must be carried out by health workers who have the appropriate knowledge and authority for that. Based on the description above, researchers are very interested in knowing whether or not there is a conformity of pharmaceutical service activities in all Banjarmasin city health centers based on Permenkes RI No. 26 of 2020 related to Pharmaceutical Service Standards. The purpose of this study was to determine the suitability of Pharmaceutical Services at public health center in Banjarmasin City against Permenkes No. 26 of 2020 concerning Pharmaceutical Service Standards at public health center. The research design method used is observation, namely making direct observations accompanied to obtain information on the Management of Pharmaceutical Supplies and Consumable Medical Materials, as well as Clinical Pharmacy Services. There are 26 health centers in Banjarmasin City. All health centers have met the suitability of pharmaceutical preparation management and Medical Consumables (BMHP) in accordance with the Minister of Health Regulation No. 26 of 2020. However, 10 public health center in Banjarmasin City have not met the requirements of clinical pharmacy services, such as Counseling, Monitoring Drug Side Effects, Monitoring Drug Therapy, and Evaluating Drug Use. This is influenced by limited human resources at these health centers. 26 health centers in Banjarmasin City are appropriate in managing pharmaceutical preparations and Consumable Medical Materials (BMHP) and 16 health centers are appropriate in implementing clinical pharmacy services.
Cost Minimization Analysis of Oral Antidiabetic Drugs in Type II Diabetes Mellitus Patiens at Sultan Suriansyah Hospital January-December 2022 Period Ain, Farah Noor; Aryzki, Saftia; Abdi, Muhammad Mahendra
Berkala Kedokteran Vol 20, No 1 (2024)
Publisher : Fakultas Kedokteran Universitas Lambung Mangkurat

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20527/jbk.v20i1.18764

Abstract

Diabetes According to WHO (2016) is a serious chronic disease that occurs when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. The high cost of treating DM patients is reaching USD 1,500 to 9,000 in developing countries. The difference in costs for oral antidiabetics and the high cost analysis method. This study aims to determine the minimum cost between metformin 500 mg and acarbose 100 mg drugs in Sultan Suriansyah Banjarmasin in adult patients. This research was conducted using a cross-sectional design based on medical records and detail of patient costs in January-December 2022. The number of sample in this study were 39 patients. The statistic analysis used in study is the Mann-Whitney test and the Independent T-Test. The result of the analysis of cost minimization based on the average total cost of therapy are Rp 419,560 for metformin 500ng and Rp 680,922 for acarbose 100 mg with a probability value > 0.05 for the cost of co morbidities which means that there is no significant difference between the two drugs. Probability value < 0.05 for antidiabetic oral drug costs, lab costs and total therapy costs which means the there is a significant difference between the two drugs. Conclusion in this study is aral antidiabetic therapy for minimal diabetes mellitus is metformin compared to acarbose.
Effectiveness of Ramania Leaves (Bouea macrophylla Griffith) from South Kalimantan as a Mosquito Larvae Biolarvicidal Aryzki, Saftia; Febrianti, Dwi Rizki
Berkala Kedokteran Vol 19, No 2 (2023)
Publisher : Fakultas Kedokteran Universitas Lambung Mangkurat

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20527/jbk.v19i2.17386

Abstract

Indonesia itself as a tropical country has many plants that can be used as biolarvicides, one of which is the ramania plant (Bouea macrophylla Griffith). Ramania fruit epidermis contains secondary metabolites such as flavonoids, saponins, phenolic tannins, alcohol, steroids and terpenoids where these compounds have a larvicidal effect. The purpose of this study was to determine the activity of the ethanol extract of the epidermis of the ramania fruit as a biolarvicidal Mosquito larvae from the LC50 value. This research is a laboratory experimental research. The treatment concentrations used in this study were 25 ppm, 50 ppm, and 100 ppm. Temephos 1% was used as a positive control. Concentrations were then tested on 20 larvae instar III. The results of SPSS analysis with a significance of <0.05 showed that there was an effect of treatment on the number of larvae deaths, where the results of Tuckey analysis showed that concentrations of 50 ppm and 100 ppm and Temephos 1% showed differences. which means the number of deaths of test larvae. The results showed that the ethanol extract of ramania rind of ramania fruit (Bouea macrophylla Griffith) was effective as a biolarvicidal mosquito larvae. The results of probit analysis showed that the LC50 of ethanol extract of ramania rind against larvae was 20,844 ppm which is a low toxic group in aquatic environments.